Pancreatic Cancer Research

ResearcherAffiliated Hospital of Qingdao UniversityActive in the last 2 years

Kang Fu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7324-911X; OpenAlex author ID A5063590142, A5138203826. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 3 papers

Papers 5

  1. The Burden of Pancreatic Cancer in ASEAN Member States (1990-2023) and Future Trends Forecasting: A GBD 2023 Analysis. Co-author DOI 10.1016/j.mayocp.2026.09.008↗
  2. The RNA methylation modification as an immunometabolic regulatory hub in pancreatic cancer: from mechanistic insights to clinical translation perspectives. Co-author DOI 10.1186/s12943-026-02667-w↗
  3. Radiomic features from intratumoral and peritumoral regions on portal venous phase CT for multicenter prediction of TP53 mutation in pancreatic cancer. Co-author DOI 10.3389/fonc.2026.1819664↗
  4. Corrigendum: The role of epigenetic regulation in pancreatic ductal adenocarcinoma progression and drug response: an integrative genomic and pharmacological pr… Co-author DOI 10.3389/fphar.2025.1560529↗
  5. The role of epigenetic regulation in pancreatic ductal adenocarcinoma progression and drug response: an integrative genomic and pharmacological prognostic pred… Co-author DOI 10.3389/fphar.2024.1498031↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiao Hu · 2 shared papers, 2024–2025 · strength 0.61
  2. S N Zhang · 1 shared paper, 2026 · strength 0.43
  3. J W Liu · 1 shared paper, 2026 · strength 0.43
  4. Xiao Hu · 1 shared paper, 2026 · strength 0.36
  5. Yangdong Wu · 1 shared paper, 2026 · strength 0.36
  6. Yinghao Zhu · 1 shared paper, 2026 · strength 0.29
  7. Zhen Tan · 1 shared paper, 2026 · strength 0.29

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.